Suppr超能文献

一些新型碳酰氨基磷酸酯类化合物作为乙酰胆碱酯酶和丁酰胆碱酯酶的抑制剂。

Some new carbacylamidophosphates as inhibitors of acetylcholinesterase and butyrylcholinesterase.

作者信息

Gholivand Khodayar, Alizadehgan Ahlam Madani, Mojahed Fresia, Dehghan Gholamreza, Mohammadirad Azadeh, Abdollahi Mohammad

机构信息

Department of Chemistry, Faculty of Sciences, Tarbiat Modarres University, P. O. Box 14115-175, Tehran, Iran.

出版信息

Z Naturforsch C J Biosci. 2008 Mar-Apr;63(3-4):241-50. doi: 10.1515/znc-2008-3-414.

Abstract

The differences in the inhibition activity of organophosphorus agents are a manifestation of different molecular properties of the inhibitors involved in the interaction with the active site of enzyme. We were interested in comparing the inhibition potency of four known synthesized carbacylamidophosphates with the general formula RC(O)NHP(O)Cl2, constituting organophosphorus compounds, where R = CCl3 (1), CHCl2 (2), CH2Cl (3) and CF3 (4), and four new ones with the general formula RC(O)NHP(O)(R')2, where R' = morpholine and R = CCl3 (5), CHCl2 (6), CH2Cl (7), CF3 (8), on AChE and BuChE activities. In addition, in vitro activities of all eight compounds on BuChE were determined. Besides, in vivo inhibition potency of compounds 2 and 6, which had the highest inhibition potency among the tested compounds, was studied. The data demonstrated that compound 2 from the compound series 1 to 4 and compound 6 from the compound series 5 to 8 are the most sensitive as AChE and BuChE inhibitors, respectively. Comparing the IC50 values of these compounds, it was clear that the inhibition potency of these compounds for AChE are 2- to 100-fold greater than for BuChE inhibition. Comparison of the kinetics (IC50, Ki, kp, KA and KD) of AChE and BuChE inactivation by these compounds resulted in no significant difference for the measured variables except for compounds 2 and 6, which appeared to be more sensitive to AChE and BuChE by significantly higher kp and Ki values and a lower IC50 value in comparison with the other compounds. The LD50 value of compounds 2 and 6, after oral administration, and the changes of erythrocyte AChE and plasma BuChE activities in albino mice were studied. The in vivo experiments, similar to the in vitro results, showed that compound 2 is a stronger AChE and BuChE inhibitor than the other synthesized carbacylamidophosphates. Furthermore, in this study, the importance of electropositivity of the phosphorus atom, steric hindrance and leaving group specificity were reinforced as important determinants of inhibition activity.

摘要

有机磷试剂抑制活性的差异体现了参与与酶活性位点相互作用的抑制剂不同的分子特性。我们感兴趣的是比较四种已知的通式为RC(O)NHP(O)Cl2的合成氨基甲酰基磷酸酯(构成有机磷化合物,其中R = CCl3 (1)、CHCl2 (2)、CH2Cl (3) 和CF3 (4))以及四种新的通式为RC(O)NHP(O)(R')2的化合物(其中R' = 吗啉且R = CCl3 (5)、CHCl2 (6)、CH2Cl (7)、CF3 (8))对乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BuChE)活性的抑制效力。此外,还测定了所有八种化合物对BuChE的体外活性。另外,研究了测试化合物中抑制效力最高的化合物2和6的体内抑制效力。数据表明,化合物系列1至4中的化合物2和化合物系列5至8中的化合物6分别是最敏感的AChE和BuChE抑制剂。比较这些化合物的IC50值可知,这些化合物对AChE的抑制效力比对BuChE的抑制效力高2至100倍。这些化合物使AChE和BuChE失活的动力学参数(IC50、Ki、kp、KA和KD)比较结果显示,除化合物2和6外,所测变量无显著差异。与其他化合物相比,化合物2和6对AChE和BuChE似乎更敏感,其kp和Ki值显著更高,IC50值更低。研究了化合物2和6经口给药后的半数致死量(LD50)值以及白化小鼠红细胞AChE和血浆BuChE活性的变化。体内实验与体外结果相似,表明化合物2是比其他合成氨基甲酰基磷酸酯更强的AChE和BuChE抑制剂。此外,在本研究中,磷原子的正电性、空间位阻和离去基团特异性的重要性作为抑制活性的重要决定因素得到了强化。

相似文献

2
Acetylcholinesterase/butyrylcholinesterase inhibition activity of some new carbacylamidophosphate derivatives.
J Enzyme Inhib Med Chem. 2009 Apr;24(2):566-76. doi: 10.1080/14756360802316971.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验